The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 355:2146-2148 November 16, 2006 Number 20
NextNext

Vasopressin Antagonists — Progress and Promise
Richard M. Hays, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Schrier, R. W.
-PubMed Citation
Hyponatremia is the most common in-hospital electrolyte disorder that a physician encounters. Its management has been the subject of numerous studies and reviews. In patients with chronic heart failure or cirrhosis, water retention, mediated by the vasopressin V2 receptor in the renal collecting tubule, is an initially positive defense against a decrease in cardiac output or the dilated splanchnic circulation in cirrhosis.1 The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is, of course, another matter. Water retention in SIADH serves no physiologic purpose, and hyponatremia may be serious enough to require emergency measures.

Until now, the management of hyponatremia has . . . [Full Text of this Article]


Source Information

From the Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.

This article was published at www.nejm.org on November 14, 2006.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.